Osteoporosis Drugs Market to be Valued USD 20.17 Billion by 2026
Rising prevalence of osteoporosis and surge in geriatric population to drive the global osteoporosis drugs market. According to TechSci Research report, “Global Osteoporosis Drugs Market By Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, and Others), By Osteoporosis Disease Type (Primary Osteoporosis, Secondary Osteoporosis), By Route of Administration (Oral, Injectable, and… Read More »
